LOTTE BIOLOGICS
Is this your company? Claim this profile
Advanced Modalities
Analytical & Bioanalytical Services
Contract Research Organization
Manufacturing & Lab Equipment
Others
Company Overview
About
LOTTE BIOLOGICS is a global biologics CDMO headquartered in South Korea, offering end-to-end development and cGMP manufacturing services for biological Drug Substance. Operates the Syracuse Bio Campus (New York, USA) with 40,000L capacity and the Songdo Bio Campus (Incheon, South Korea) planned for 120,000L by 2027. Also operates a $100M ADC manufacturing facility.
Therapeutic Areas
Oncology
Quick Facts
HQ:South Korea
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Drug Product
- Antibody-Drug Conjugates (ADC)
Production Scales
Clinical
Markets Served
Asia
North America
Manufacturing Facilities
2 sites worldwide
LOTTE BIOLOGICS - South Korea Facility
South Korea
Site Capabilities
3 capabilitiesQuality Control
Stability Testing
Method Development
LOTTE BIOLOGICS - United States Facility
United States
Site Capabilities
3 capabilitiesQuality Control
Stability Testing
Method Development